Nurse Practitioner, Family · Las Vegas, NV
NPI
1518605237
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2650 N Tenaya Way Ste 201
Las Vegas, NV, 89128
Phone (702) 735-7154
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.2M
1,052 prescriptions
Company payments, 2025
$556
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug John Eusebio prescribed most often to Medicare patients was Anastrozole, with 154 prescriptions and refills. In total John Eusebio wrote 1,052 Medicare prescriptions that cost $5.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 154 | 397 | 56 | $3,072 |
| Exemestane Generic | 53 | 119 | 14 | $7,486 |
| Ondansetron Hcl Generic | 48 | 48 | 36 | $1,274 |
| Calquence Acalabrutinib Maleate | 41 | 41 | Under 11 | $578K |
| Eliquis Apixaban | 34 | 38 | Under 11 | $22K |
| Dexamethasone Generic | 33 | 48 | 13 | $664 |
| Lenalidomide Generic | 27 | 27 | Under 11 | $373K |
| Letrozole Generic | 26 | 68 | 13 | $504 |
| Alendronate Sodium Generic | 25 | 39 | Under 11 | $93.19 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | 15 | $494 |
| Gabapentin Generic | 23 | 33 | Under 11 | $177 |
| Kisqali Ribociclib Succinate | 23 | 23 | Under 11 | $373K |
| Revlimid Lenalidomide | 23 | 23 | Under 11 | $381K |
| Acyclovir Generic | 23 | 27 | Under 11 | $179 |
| Kyprolis Carfilzomib | 22 | 22 | Under 11 | $232K |
Brand drugs: 380 claims; generic drugs: 672 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Eusebio $556 ($556 in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.